{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:09:30Z","timestamp":1776384570401,"version":"3.51.2"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jbc.2026.111212","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:39:22Z","timestamp":1769701162000},"page":"111212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIF-2\u03b1 induction in de novo lipogenesis in metabolic dysfunction-associated steatohepatitis is dependent on IL-21 signaling"],"prefix":"10.1016","volume":"302","author":[{"given":"Karla K.","family":"Frietze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6900-9428","authenticated-orcid":false,"given":"Alyssa","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dividutta","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Franks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranavi","family":"Jagadeesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9984-3056","authenticated-orcid":false,"suffix":"Jr.","given":"Joseph T.","family":"Nickels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111212_bib1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","article-title":"New and emerging treatments for metabolic dysfunction-associated steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2026.111212_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jbc.2026.111212_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s13679-023-00527-y","article-title":"Update on the obesity epidemic: after the sudden rise, is the upward trajectory beginning to flatten?","volume":"12","author":"Koliaki","year":"2023","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.jbc.2026.111212_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","article-title":"Healthcare and socioeconomic costs of NAFLD: a global framework to navigate the uncertainties","volume":"79","author":"Allen","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jbc.2026.111212_bib5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2026.111212_bib6","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/biomedicines13092079","article-title":"Resmetirom for MASH: a comprehensive review of a novel therapeutic frontier","volume":"13","author":"Tiwari","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbc.2026.111212_bib7","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41587-025-02828-0","article-title":"Wegovy approved for MASH","volume":"43","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2026.111212_bib8","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/s41366-025-01859-6","article-title":"Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis","volume":"49","author":"Ismaiel","year":"2025","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.jbc.2026.111212_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1900\/RDS.2014.11.202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos","year":"2014","journal-title":"Rev. Diabet Stud."},{"key":"10.1016\/j.jbc.2026.111212_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13098-023-01233-4","article-title":"Pharmacotherapy for obesity: moving towards efficacy improvement","volume":"16","author":"Coutinho","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.jbc.2026.111212_bib11","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7634.1","article-title":"IL-21 signaling in immunity","volume":"5","author":"Leonard","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.jbc.2026.111212_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.coi.2015.02.010","article-title":"Advances in IL-21 biology - enhancing our understanding of human disease","volume":"34","author":"Tangye","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jbc.2026.111212_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrd4296","article-title":"Interleukin-21: a double-edged sword with therapeutic potential","volume":"13","author":"Spolski","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2026.111212_bib14","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2006-10-054973","article-title":"The molecular basis of IL-21-mediated proliferation","volume":"109","author":"Zeng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111212_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","article-title":"Interleukin-21: basic biology and implications for cancer and autoimmunity","volume":"26","author":"Spolski","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jbc.2026.111212_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.jbc.2026.111212_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12943-024-02001-2","article-title":"Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA(+) B cells","volume":"23","author":"Xie","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111212_bib18","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2147\/JIR.S452061","article-title":"Correlation analysis of IL-17, IL-21, IL-23 with non-alcoholic liver fibrosis and cirrhosis","volume":"17","author":"Yang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.jbc.2026.111212_bib19","article-title":"The role of the interleukin family in liver fibrosis","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.jbc.2026.111212_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7111445","article-title":"The proinflammatory cytokines IL-18, IL-21, and IFN-gamma differentially regulate liver inflammation and anti-mitochondrial antibody level in a murine model of primary biliary cholangitis","volume":"2022","author":"Xu","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jbc.2026.111212_bib21","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI27727","article-title":"The IL-21 receptor augments Th2 effector function and alternative macrophage activation","volume":"116","author":"Pesce","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111212_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.molimm.2021.03.005","article-title":"IFN-gamma contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1beta\/TLR2 signaling pathway","volume":"134","author":"Li","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbc.2026.111212_bib23","doi-asserted-by":"crossref","first-page":"E198","DOI":"10.1111\/hepr.12215","article-title":"Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells","volume":"44","author":"Feng","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jbc.2026.111212_bib24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2026.111212_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/obr.12020","article-title":"Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis","volume":"14","author":"Musso","year":"2013","journal-title":"Obes. Rev."},{"key":"10.1016\/j.jbc.2026.111212_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112628","article-title":"Sleep apnea and sleep habits: relationships with metabolic syndrome","volume":"11","author":"Borel","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jbc.2026.111212_bib27","article-title":"Hypoxia and non-alcoholic fatty liver disease","volume":"7","author":"Isaza","year":"2020","journal-title":"Front Med. (Lausanne)"},{"key":"10.1016\/j.jbc.2026.111212_bib28","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1152\/japplphysiol.00522.2005","article-title":"Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice","volume":"99","author":"Li","year":"2005","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.jbc.2026.111212_bib29","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1152\/ajpendo.00052.2019","article-title":"Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2alpha\/PPARalpha pathway","volume":"317","author":"Chen","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2026.111212_bib30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s12072-022-10347-2","article-title":"Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity","volume":"16","author":"Fu","year":"2022","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jbc.2026.111212_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbrc.2021.01.002","article-title":"Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-kappaB signalling pathway","volume":"540","author":"Cai","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2026.111212_bib32","article-title":"Hypoxia-Inducible factors as key players in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"8","author":"Holzner","year":"2021","journal-title":"Front Med. (Lausanne)"},{"key":"10.1016\/j.jbc.2026.111212_bib33","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/ATVBAHA.115.305476","article-title":"Loss of interleukin-21 receptor activation in hypoxic endothelial cells impairs perfusion recovery after hindlimb ischemia","volume":"35","author":"Wang","year":"2015","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jbc.2026.111212_bib35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12967-021-02854-x","article-title":"The roles and mechanisms of hypoxia in liver fibrosis","volume":"19","author":"Cai","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jbc.2026.111212_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.2005.071118","article-title":"Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice","volume":"55","author":"Tomita","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jbc.2026.111212_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007929","article-title":"IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis","volume":"4","author":"Mas","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111212_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/15548627.2021.1920818","article-title":"Lipotoxicity reduces DDX58\/Rig-1 expression and activity leading to impaired autophagy and cell death","volume":"18","author":"Frietze","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.jbc.2026.111212_bib39","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1091\/mbc.E15-01-0036","article-title":"CHOP links endoplasmic reticulum stress to NF-kappaB activation in the pathogenesis of nonalcoholic steatohepatitis","volume":"26","author":"Willy","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2026.111212_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021381","article-title":"Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis","volume":"6","author":"Zimmermann","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111212_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physrev.00045.2017","article-title":"The TNF family of ligands and receptors: communication modules in the immune system and beyond","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jbc.2026.111212_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70322","article-title":"Relation of 91 circulating inflammatory proteins to nonalcoholic fatty liver disease: a two-sample mendelian randomisation study","volume":"28","author":"Wu","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jbc.2026.111212_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186421","article-title":"Dissecting the mechanisms of MASLD fibrosis in the era of single-cell and spatial omics","volume":"135","author":"Colella","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111212_bib44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000514848","article-title":"Triglycerides mediate body mass index and nonalcoholic fatty liver disease: a population-based study","volume":"14","author":"Xing","year":"2021","journal-title":"Obes. Facts"},{"key":"10.1016\/j.jbc.2026.111212_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"Sattar","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jbc.2026.111212_bib46","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/clinchem\/31.12.1959","article-title":"Macro creatine kinase type 2: results of a prospective study in hospitalized patients","volume":"31","author":"Stein","year":"1985","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jbc.2026.111212_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-230X-5-9","article-title":"Elevated creatine kinase activity in primary hepatocellular carcinoma","volume":"5","author":"Meffert","year":"2005","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.jbc.2026.111212_bib48","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41423-025-01307-5","article-title":"Immunopathogenic mechanisms and immunoregulatory therapies in MASLD Cell","volume":"22","author":"He","year":"2025","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbc.2026.111212_bib49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jbc.2026.111212_bib50","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jcmgh.2023.02.010","article-title":"Hepatic Stellate cells: dictating outcome in nonalcoholic fatty liver disease","volume":"15","author":"Wiering","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jbc.2026.111212_bib51","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3390\/cells8101184","article-title":"Characterization of the roles of vimentin in regulating the proliferation and migration of HSCs during hepatic fibrogenesis","volume":"8","author":"Wang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2026.111212_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80010-5","article-title":"The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo","volume":"30","author":"Hellerbrand","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jbc.2026.111212_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2026.111212_bib54","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-065X.2008.00760.x","article-title":"SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels","volume":"228","author":"Lorenz","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jbc.2026.111212_bib55","doi-asserted-by":"crossref","first-page":"40475","DOI":"10.1074\/jbc.M402970200","article-title":"Regulation of SHP-1 tyrosine phosphatase in human platelets by serine phosphorylation at its C terminus","volume":"279","author":"Jones","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111212_bib56","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.24400","article-title":"Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis","volume":"54","author":"Qu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2026.111212_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41574-018-0096-z","article-title":"The role of hypoxia-inducible factors in metabolic diseases","volume":"15","author":"Gonzalez","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jbc.2026.111212_bib58","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1182\/blood-2010-08-303669","article-title":"Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells","volume":"117","author":"Fatrai","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111212_bib59","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1159\/000366348","article-title":"Hypoxia induces dysregulation of lipid metabolism in HepG2 cells via activation of HIF-2alpha","volume":"34","author":"Cao","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jbc.2026.111212_bib60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41588-017-0027-2","article-title":"An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111212_bib61","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111212_bib62","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2026.111212_bib63","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.molcel.2012.09.017","article-title":"HIF2alpha acts as an mTORC1 activator through the amino acid carrier SLC7A5","volume":"48","author":"Elorza","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111212_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111212_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41467-020-20185-1","article-title":"p62\/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response","volume":"12","author":"Kageyama","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111212_bib66","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/hepr.13071","article-title":"Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease","volume":"48","author":"Fukushima","year":"2018","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jbc.2026.111212_bib67","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41419-022-05061-8","article-title":"Autophagic sequestration of SQSTM1 disrupts the aggresome formation of ubiquitinated proteins during proteasome inhibition","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111212_bib68","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4161\/auto.7.11.17661","article-title":"A comprehensive glossary of autophagy-related molecules and processes","volume":"7","author":"Klionsky","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.jbc.2026.111212_bib69","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2026.111212_bib70","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2005.09.033","article-title":"Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34","volume":"123","author":"Petroski","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111212_bib71","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.it.2016.06.001","article-title":"IL-21 and T cell differentiation: consider the context","volume":"37","author":"Tian","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jbc.2026.111212_bib72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2026.111212_bib73","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91001","article-title":"Adipocyte JAK2 mediates growth hormone-induced hepatic insulin resistance","volume":"2","author":"Corbit","year":"2017","journal-title":"JCI Insight."},{"key":"10.1016\/j.jbc.2026.111212_bib74","article-title":"Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma","volume":"5","author":"Corbit","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2026.111212_bib75","doi-asserted-by":"crossref","first-page":"19455","DOI":"10.1073\/pnas.1008271107","article-title":"Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling","volume":"107","author":"Rochman","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111212_bib76","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0960-9822(06)00369-1","article-title":"Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation","volume":"7","author":"Liu","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2026.111212_bib77","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12967-022-03366-y","article-title":"Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1\/2","volume":"20","author":"Song","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jbc.2026.111212_bib78","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1158\/1078-0432.CCR-16-2253","article-title":"Multifunctional effects of a small-molecule STAT3 inhibitor on NASH and hepatocellular carcinoma in mice","volume":"23","author":"Jung","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111212_bib79","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"Brenner","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jbc.2026.111212_bib80","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hep.23148","article-title":"Immature myeloid cells induced by a high-fat diet contribute to liver inflammation","volume":"50","author":"Deng","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2026.111212_bib81","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-kappaB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2026.111212_bib82","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41419-019-1828-2","article-title":"mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111212_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.10.010","article-title":"Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression","volume":"124","author":"Kaltenecker","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.jbc.2026.111212_bib84","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1182\/blood-2007-08-105643","article-title":"IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis","volume":"111","author":"Scheeren","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111212_bib85","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.24509","article-title":"Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice","volume":"54","author":"Mueller","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2026.111212_bib86","doi-asserted-by":"crossref","first-page":"42762","DOI":"10.18632\/oncotarget.8641","article-title":"Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111212_bib87","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher's guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jbc.2026.111212_bib88","doi-asserted-by":"crossref","first-page":"109","DOI":"10.21037\/atm-21-4222","article-title":"Regulatory mechanism of HIF-1alpha and its role in liver diseases: a narrative review","volume":"10","author":"Chu","year":"2022","journal-title":"Ann. Transl Med."},{"key":"10.1016\/j.jbc.2026.111212_bib89","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1073\/pnas.1705304114","article-title":"mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells","volume":"114","author":"Eid","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111212_bib90","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3465","article-title":"Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol","volume":"9","author":"Crowe","year":"2019","journal-title":"Bio Protoc."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826000827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826000827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:28:14Z","timestamp":1776382094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0021925826000827"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111212","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIF-2\u03b1 induction in de novo lipogenesis in metabolic dysfunction-associated steatohepatitis is dependent on IL-21 signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111212"}}